Table 2.

Baseline characteristics from MS patients (n = 18) included in the CSF study population.

	MS patients (n = 18)
Age	43.8 ± 3
Gender (female), %	78%
[glucose] CSF, mg/dL	61.3 ± 1
Medication use, %	33%
Clinically isolated syndrome, %	6%
Relapsing remitting MS, %	50%
Secondary progressive MS, %	44%
EDSS	4.2 ± 0.6
Duration of disease, years	6.4 ± 2
Number of relapses	2.6 ± 0.3

Duration of disease is determined as time between diagnosis and sampling of CSF. Data is presented as Mean ± SEM or as percentage of the total group.